WO2000010547A3 - Nouvelle utilisation de derives taxoides - Google Patents

Nouvelle utilisation de derives taxoides Download PDF

Info

Publication number
WO2000010547A3
WO2000010547A3 PCT/EP1999/006292 EP9906292W WO0010547A3 WO 2000010547 A3 WO2000010547 A3 WO 2000010547A3 EP 9906292 W EP9906292 W EP 9906292W WO 0010547 A3 WO0010547 A3 WO 0010547A3
Authority
WO
WIPO (PCT)
Prior art keywords
new use
hydroxy
colon cancer
relates
present
Prior art date
Application number
PCT/EP1999/006292
Other languages
English (en)
Other versions
WO2000010547A2 (fr
Inventor
Marie-Christine Bissery
Patricia Vrignaud
Simon Roberts
Clive Brealey
Original Assignee
Aventis Pharma Sa
Bissery Marie Christine
Patricia Vrignaud
Simon Roberts
Clive Brealey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP98115650A external-priority patent/EP0982028A1/fr
Priority to SK235-2001A priority Critical patent/SK2352001A3/sk
Priority to KR1020017002136A priority patent/KR20010079665A/ko
Priority to EA200100250A priority patent/EA200100250A1/ru
Priority to MXPA01001721A priority patent/MXPA01001721A/es
Priority to AU57420/99A priority patent/AU5742099A/en
Priority to IL14123199A priority patent/IL141231A0/xx
Priority to CA002341191A priority patent/CA2341191A1/fr
Application filed by Aventis Pharma Sa, Bissery Marie Christine, Patricia Vrignaud, Simon Roberts, Clive Brealey filed Critical Aventis Pharma Sa
Priority to EP99944532A priority patent/EP1105119A2/fr
Priority to JP2000565869A priority patent/JP2002523364A/ja
Priority to BR9913071-8A priority patent/BR9913071A/pt
Priority to HU0104000A priority patent/HUP0104000A3/hu
Priority to EEP200100082A priority patent/EE200100082A/xx
Publication of WO2000010547A2 publication Critical patent/WO2000010547A2/fr
Publication of WO2000010547A3 publication Critical patent/WO2000010547A3/fr
Priority to NO20010655A priority patent/NO20010655D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne une nouvelle utilisation de dérivés taxoïdes et plus précisément une méthode de traitement de la prolifération cellulaire anormale de différentes lignées cellulaires exprimant de la P-glycoprotéine résistant à l'action de plusieurs médicaments. Ce type de cellules est représentatif des cellules du cancer du côlon. Les produits de l'invention peuvent également être utilisés pour le traitement du cancer du côlon chez les mammifères dont l'homme.
PCT/EP1999/006292 1998-08-20 1999-08-18 Nouvelle utilisation de derives taxoides WO2000010547A2 (fr)

Priority Applications (13)

Application Number Priority Date Filing Date Title
EEP200100082A EE200100082A (et) 1998-08-20 1999-08-18 Taksoidi derivaatide kasutamine ravimi valmistamiseks, mis on ette nähtud rakkude ebaloomuliku proliferatsiooni raviks laiaspektrilise ravimresistentsusega P-glükoproteiini ekspresseerivates rakuliinides
CA002341191A CA2341191A1 (fr) 1998-08-20 1999-08-18 Nouvelle utilisation de derives taxoides
EA200100250A EA200100250A1 (ru) 1998-08-20 1999-08-18 Новое применение таксоидных производных
MXPA01001721A MXPA01001721A (es) 1998-08-20 1999-08-18 Nuevo uso de derivados de taxoide.
EP99944532A EP1105119A2 (fr) 1998-08-20 1999-08-18 Nouvelle utilisation de derives taxoides
IL14123199A IL141231A0 (en) 1998-08-20 1999-08-18 New use of taxoid derivatives
KR1020017002136A KR20010079665A (ko) 1998-08-20 1999-08-18 탁소이드 유도체의 신규 용도
SK235-2001A SK2352001A3 (en) 1998-08-20 1999-08-18 New use of taxoid derivatives
AU57420/99A AU5742099A (en) 1998-08-20 1999-08-18 New use of taxoid derivatives
JP2000565869A JP2002523364A (ja) 1998-08-20 1999-08-18 タキソイド誘導体の新規な使用
BR9913071-8A BR9913071A (pt) 1998-08-20 1999-08-18 Uso de um composto derivado de taxóide
HU0104000A HUP0104000A3 (en) 1998-08-20 1999-08-18 New use of taxoid derivatives
NO20010655A NO20010655D0 (no) 1998-08-20 2001-02-07 Ny anvendelse av taxoidderivater

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP98115650.8 1998-08-20
EP98115650A EP0982028A1 (fr) 1998-08-20 1998-08-20 Nouvelle utilisation de dérivés de taxoides
US12384399P 1999-03-11 1999-03-11
US60/123,843 1999-03-11

Publications (2)

Publication Number Publication Date
WO2000010547A2 WO2000010547A2 (fr) 2000-03-02
WO2000010547A3 true WO2000010547A3 (fr) 2000-06-29

Family

ID=26149552

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1999/006292 WO2000010547A2 (fr) 1998-08-20 1999-08-18 Nouvelle utilisation de derives taxoides

Country Status (15)

Country Link
EP (1) EP1105119A2 (fr)
JP (1) JP2002523364A (fr)
KR (1) KR20010079665A (fr)
CN (1) CN1313764A (fr)
AU (1) AU5742099A (fr)
BG (1) BG105273A (fr)
CA (1) CA2341191A1 (fr)
EE (1) EE200100082A (fr)
HU (1) HUP0104000A3 (fr)
IL (1) IL141231A0 (fr)
MX (1) MXPA01001721A (fr)
NO (1) NO20010655D0 (fr)
SK (1) SK2352001A3 (fr)
TR (1) TR200100575T2 (fr)
WO (1) WO2000010547A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2922107B1 (fr) * 2007-10-10 2010-02-26 Aventis Pharma Sa Nouvelles compositions a base de taxoides
BR112012011457A2 (pt) 2009-10-29 2016-05-03 Aventis Pharma Sa uso antitumoral de cabazitaxel.

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994010169A1 (fr) * 1992-10-30 1994-05-11 Rhone-Poulenc Rorer S.A. Procede de preparation de derives du taxane
WO1996030355A1 (fr) * 1995-03-27 1996-10-03 Rhone-Poulenc Rorer S.A. Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
WO1996032387A1 (fr) * 1995-04-14 1996-10-17 Rhone-Poulenc Rorer S.A. Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994010169A1 (fr) * 1992-10-30 1994-05-11 Rhone-Poulenc Rorer S.A. Procede de preparation de derives du taxane
WO1996030355A1 (fr) * 1995-03-27 1996-10-03 Rhone-Poulenc Rorer S.A. Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
WO1996032387A1 (fr) * 1995-04-14 1996-10-17 Rhone-Poulenc Rorer S.A. Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
CN1313764A (zh) 2001-09-19
TR200100575T2 (tr) 2001-07-23
NO20010655L (no) 2001-02-07
IL141231A0 (en) 2002-03-10
BG105273A (en) 2001-11-30
MXPA01001721A (es) 2005-06-03
SK2352001A3 (en) 2001-07-10
JP2002523364A (ja) 2002-07-30
AU5742099A (en) 2000-03-14
KR20010079665A (ko) 2001-08-22
CA2341191A1 (fr) 2000-03-02
WO2000010547A2 (fr) 2000-03-02
EE200100082A (et) 2002-06-17
EP1105119A2 (fr) 2001-06-13
NO20010655D0 (no) 2001-02-07
HUP0104000A3 (en) 2003-01-28
HUP0104000A2 (hu) 2002-04-29

Similar Documents

Publication Publication Date Title
WO2001052904A3 (fr) Compositions renfermant des oligonucleotides antisens diriges contre le vegf et methodes associees
WO2002056022A3 (fr) Marqueurs tumoraux de diagnostic, analyse de medicaments pour l'inhibition de la tumorigenese, et compositions et procedes pour le traitement du cancer
AU2003228467A1 (en) Moisture resistant, repulpable paper products and method of making same
PL350246A1 (en) Triazole compounds with dopamine-d3-receptor affinity
MY135734A (en) Clinical parameters for determining hematologic toxicity prior to radioimmunotherapy
AU4372997A (en) On-line, thermo-chemical process for the dewaxing of oil export pipelines
WO1997038966A3 (fr) Composes cytoprotecteurs
PL365747A1 (en) Catalysts which are based on organic-inorganic hybrid materials containing noble metals and titanium and which are used for selectively oxidizing hydrocarbons
CA2340921A1 (fr) Utilisation de taxanes pour traiter le cancer du cerveau
WO2000010547A3 (fr) Nouvelle utilisation de derives taxoides
AUPO684997A0 (en) Polyphenol oxidase genes from banana, tobacco & pineapple
WO2000015209A3 (fr) Regulation de l'expression oncongene de her2/neu par des polyamides synthetiques
WO2005019269A3 (fr) Techniques et compositions pour le diagnostic et le traitement du cancer (muc1)
AU6279500A (en) Epothilone compositions
AU2002238195A1 (en) Method for recovering material values from bisphenol tars
WO2004045545A3 (fr) Compositions et procedes destines au traitement du cancer, au criblage des composants anticancereux presumes et a l'estimation de l'evolution du cancer
EA200100250A1 (ru) Новое применение таксоидных производных
WO2005012275A3 (fr) Composes benzo[1,2,5]thiadiazole
AU5585700A (en) Process for making 2,4,6, 8,10,12- hexanitro- 2,4,6,8,10, 12- hexa azatetracyclo(5.5.0. 05,9.03,11} -dodecane
ZA200006004B (en) Methods and useful intermediates for paclitaxel synthesis from C-7, C-10 di-CBZ 10-Deacetylbaccatin III.
AU6726700A (en) Method of treating 1,1,1,3,3-pentafluoropropane
WO2003002765A3 (fr) Cancer
AU2003215762A1 (en) Treating cancer
AU6091499A (en) Method for separating reduced sulphur compounds from concentrated odour gases ofa pulp mill
AU2003264707A1 (en) Use of a chrysanthellum extract

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 99809900.7

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AU BA BB BG BR CA CN CR CU CZ DM EE GD GE HR HU ID IL IN IS JP KP KR LC LK LR LT LV MG MK MN MX NO NZ PL RO RU SG SI SK SL TR TT UA US UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AU BA BB BG BR CA CN CR CU CZ DM EE GD GE HR HU ID IL IN IS JP KP KR LC LK LR LT LV MG MK MN MX NO NZ PL RO RU SG SI SK SL TR TT UA US UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 141231

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: P-80/01

Country of ref document: YU

WWE Wipo information: entry into national phase

Ref document number: 1999944532

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: PA/a/2001/001721

Country of ref document: MX

Ref document number: PV2001-603

Country of ref document: CZ

WWE Wipo information: entry into national phase

Ref document number: 2352001

Country of ref document: SK

ENP Entry into the national phase

Ref document number: 2341191

Country of ref document: CA

Ref document number: 2341191

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 510039

Country of ref document: NZ

Ref document number: 1020017002136

Country of ref document: KR

ENP Entry into the national phase

Ref document number: 1999 105273

Country of ref document: BG

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2001/01414

Country of ref document: ZA

Ref document number: 57420/99

Country of ref document: AU

Ref document number: 200101414

Country of ref document: ZA

Ref document number: IN/PCT/2001/00163/DE

Country of ref document: IN

Ref document number: 2001/00575

Country of ref document: TR

WWE Wipo information: entry into national phase

Ref document number: 200100250

Country of ref document: EA

ENP Entry into the national phase

Ref document number: 20010217

Country of ref document: UZ

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1200100267

Country of ref document: VN

WWP Wipo information: published in national office

Ref document number: 1999944532

Country of ref document: EP

Ref document number: PV2001-603

Country of ref document: CZ

WWP Wipo information: published in national office

Ref document number: 1020017002136

Country of ref document: KR

WWW Wipo information: withdrawn in national office

Ref document number: 1999944532

Country of ref document: EP

WWR Wipo information: refused in national office

Ref document number: PV2001-603

Country of ref document: CZ

WWW Wipo information: withdrawn in national office

Ref document number: 1020017002136

Country of ref document: KR